Considering the results of that study together with those of the current one, we concluded that in patients with advanced gastric carcinomas, PKCα mRNA plays a promoting role in decreased survival, whereas PKCα protein has an opposing effect to suppress cancer progression and decrease cancer mortality. Here, PRKCA is linked to cancer.